Trypanosoma Cruzi Infection: Clinical Trials

3 trials for Trypanosoma Cruzi Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Trypanosoma Cruzi Infection: new trials by email Literature Review of Trypanosoma Cruzi Infection trials Research Report on Trypanosoma Cruzi Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
University-Based Chagas Testing in Salta Province, Argentina
Rapid diagnostic test (RDT) for Trypanosoma cruzi infection. - Chagas Disease, Trypanosoma Cruzi Infection
CompletedMundo Sano Foundation25682024-09-112026-06-23
New Therapies and Biomarkers for Chagas Infection
Benznidazole, Nifurtimox - Trypanosoma Cruzi Infection, Chagas Disease
Phase 2CompletedUniversity of Texas, El Paso4502019-12-182024-07-17
Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.
Benznidazole - Chagas Disease, Trypanosoma Cruzi Infection
Phase 2CompletedHospital Universitari Vall d'Hebron Research Institute2382017-04-212023-12-19

Narrower conditions

Chagas Disease (3)  ·  Parasitic Diseases (1)

Broader conditions

Euglenozoa Infections (3)  ·  Infections (3)  ·  Protozoan Infections (3)  ·  Trypanosomiasis (3)  ·  Vector Borne Diseases (3)  ·  Parasitic Diseases (2)

Interventions

benzonidazole (2)  ·  Nifurtimox (1)  ·  Rapid Diagnostic Tests (1)

Sponsors

Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Mundo Sano Foundation (1)  ·  University of Texas, El Paso (1)

Countries

Argentina (2)  ·  Bolivia (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Spain (1)

Top investigators

Adriana Echazu, PhD (1)  ·  Faustino Torrico, M.D., Ph.D (1)  ·  Igor C Almeida, D.Sc. (1)  ·  Israel Molina, PhD (1)  ·  Joaquim Gascon, M.D., Ph.D (1)  ·  Ruben O Cimino, PhD (1)

Results publications

PMID 32293523, PMID 34972765, PMID 38218195, PMID 42772313

NIH funding

2016 (1), U01AI129783 (1)